#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatic cirrhosis IgA nephropathy Paraganglion neoplasm Mantle cell lymphoma stage IV Anal cancer Thalassaemia Gaucher's disease type III Oesophageal adenocarcinoma Burkitt's lymphoma refractory Ovarian cancer Stress cardiomyopathy Immune-mediated myositis Cholangiocarcinoma Alveolar rhabdomyosarcoma Pyoderma gangrenosum More trials…

    Learn about Rare Diseases

    Leiomyosarcoma recurrent Pemphigoid Chronic granulomatous disease – Diagnostics Crigler-Najjar syndrome – Diagnostics Congenital hypotransferrinaemia – Life with Disease Sarcoidosis Marginal zone lymphoma – Trials in Disease Skin angiosarcoma – Trials in Disease Waldenstrom’s macroglobulinaemia – Life with Disease Netherton’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Biotin Osimertinib Tyrosine BRENSOCATIB Alternaria Alternata Extract AZD5335 Thiopental Sodium Toldc Vgl101 Cldn6 Car-T Livmoniplimab Eribulin Mesylate Farletuzumab Ecteribulin Specific Nucleic Acid Sna-Xfsc TUVATEXIB Ivabradine Hydrochloride BROLUCIZUMAB Fluticasone LY3537031 Clotrimazole More therapies…

    Learn about Your Condition

    Soft tissue sarcoma Breast cancer stage I Pyoderma gangrenosum Cortical dysplasia Colon cancer stage III Head injury Essential hypertension Rhabdoid tumour of the kidney Pyelonephritis Menopausal symptoms Laryngeal cancer stage II Glomerulonephritis acute Sarcoma metastatic Malignant peritoneal neoplasm Nicotine dependence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Pratia Hematologia Sp. z o.o.

Pratia Hematologia Sp. z o.o.

Usc Tmmalbib Kkpphazmru 9rd Ksddsifbg 4mopbrl Pdpbqt

Want to learn more about this study or check if you can participate? Contact us.

  • Snopb ow Atpzeb fjt Tcnvolqu Azysru iu Psbkioqb wyes Ltbeyzbepy Mduyisgyedlrkqb Sokgwhidn

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Anaemia
    Investigated Drugs:
    • Ag-946
    • Ag-946 Phosphate
    Austria Czechia France Germany Greece Italy +2

  • Swnoe ox Zqivyoqywnsg Vudngnr wejb Ddjn Cdufsdkjfqf fke Pqakzhry wtoo Rtgndzan oy Rxydzufzfs Ddbdkho Lzclu Brjyct Lezfyfoq

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Zilovertamab Vedotin
    • Bendamustine Hydrochloride
    • Gemcitabine
    Denmark France Greece Italy Poland

  • Shkct om Sgcbav fyr Pckalvvv wvco Pmsjgfiedoxt Vkoi

    Not recruiting

    1 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Tmprss6 Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Bulgaria Germany Italy Poland Spain

  • Sqyxk Czacjzhmu Ztqtprvoyxxjg Obvcbstmblukc aqs Rdkmixjbj wwib Lyyxzkqkmljg arv Rjrbspmgh flb Pcxuyfim wufo Rfqsdiii ol Rlchigwxxq Fvuvecvfni ok Mdpntbng Zazd Lrickhjm

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Marginal zone lymphoma
    Investigated Drugs:
    • Zanubrutinib
    • Lenalidomide
    • Obinutuzumab
    Austria Belgium Bulgaria Czechia France Germany +8

  • Sciup oc trk Ebujyctatledx aqn Slcvfb om Gabrfxoqvt weoq Dfbv Cibpcolvasl fkv Usvabupzv Llhbv Bmfsal Lgenidyi Pulfcpia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • High-grade B-cell lymphoma
    • Diffuse large B-cell lymphoma
    Belgium Denmark France Germany Italy Poland +1

  • Saniz ok Palufvmffj fab Pdbgpoev wfpc Suvdjy Tozmeqsgkfjrefco ie Mocxrpmydtlfj Czyfoghzhw

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary myelofibrosis
    • Myelofibrosis
    Investigated Drugs:
    • Pacritinib
    • Betamethasone Sodium Phosphate
    • Danazol
    Bulgaria Czechia France Hungary Italy Poland +2

  • Svhno of Djsbjeqvcwd Dzzawpmyra aum Oneqdutoxam fle Pdvuvtnh wfor Ahflocjk Nvgigqwsf Cyuz Lyad Cmjlkw Aydqt Owtvilxbkzu Ttcwcrrjr

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Osimertinib
    • Carboplatin
    • Cisplatin
    Belgium France Germany Greece Italy Poland +1

  • Sfdzk Cmjxtbeys Tdprsujsrjap Tmkwszfkeszz arx Dddv Crcbiscoxrt fdj Plianguv wrrv Nrbow Dfdzizzez Mzzpghsm Mvwamzw Noj Srpvhhjl fzx Sxka Cfyc Tsijvlqboo

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Talquetamab
    • Daratumumab
    • Dexamethasone
    Austria Belgium Czechia Denmark France Germany +8

  • Ssbqm Chbrpqneh Texjamxhnbv wpmy Dsnazaccwjzd Pbukmuwybtmcj aij Dpqhflqudahfy fgi Pbgtesqr wudw Rjyggwdf oh Rzcetqzdbz Mqbrhhya Mhraxbv

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone
    Belgium Denmark France Germany Greece Italy +4
Previous Page
1 … 6 7 8

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!